software industry

MongoDB's chief executive Dev Ittycheria's successor situation is in flux as reports say the CEO, Desai, is stepping down to lead Meta's enterprise platform efforts. The move takes one of the database industry's most prominent leaders to the social media giant, raising questions about MongoDB's leadership transition and Meta's push into enterprise infrastructure.

Security company Legit Security has launched an agentic remediation product that automatically fixes vulnerabilities in open-source software dependencies. The announcement was picked up by several technology outlets including TechCrunch, Hackread and DevOps.com. The tool uses autonomous AI agents to detect and patch flaws in software supply chains, reflecting growing industry interest in applying AI agents to security operations and code remediation.

Weidmuller has put forward a definition of open automation, describing it as application freedom combined with interoperability between systems. The industrial technology company's framing signals a push for automation solutions that are not locked to a single vendor's ecosystem, allowing users to choose and combine components freely. The announcement is being circulated among industry and automation software observers.

A Hacker News discussion thread asks who still runs DOS machines that their business genuinely depends on. The prompt invites stories of legacy computing: factories, labs, or offices keeping decades-old MS-DOS or PC DOS systems alive because critical software or hardware was never ported to modern platforms. Commenters typically share examples of industrial controllers, embedded equipment, and the challenges of maintaining obsolete hardware, with debate over why such systems persist and how risky they are.

Veeva Systems Inc., the US life-sciences software company trading under the ticker VEEV, is seeing renewed attention on its stock price, quote and trading history. Investors are checking the latest news and market data on the company, which provides cloud-based software to the pharmaceutical and biotech industries.